Sunday, March 05, 2023 5:15:53 PM
skitahoe,
Think about it this way. What is it that investors were expecting to have happen on May 10th with news of a positive trial outcome? The price typically rises to a point somewhere between a high and a low just prior to when a news release event is considered binary right? Ok, if we can agree on that then good news typically would take the price to double or more and a 150% gain is even fairly typical. The equivalent in the opposite direction comes in at a 75% loss. That would have been around $5. Instead the price was dropped to the last remaining uptrend line at about $.385 and bounced up off of that to right about a 75% loss. That “correction” was created by turning “good news into bad” AGAIN by fabrications about the importance of PFS and spoofing/shorting designed to take out stop losses and get non professional investors to panic sell creating even more momentum.
I stated once before that I believed that the damages should conservatively be noted (a good case could be made) to be about $5,000,000,000. Depending on what jurors might think the May 10th news should have been worth it could be more than that which you allude to. Citadel’s big profits from last year might be seen in a whole new light by jurors once discovery occurs. Best wishes.
Think about it this way. What is it that investors were expecting to have happen on May 10th with news of a positive trial outcome? The price typically rises to a point somewhere between a high and a low just prior to when a news release event is considered binary right? Ok, if we can agree on that then good news typically would take the price to double or more and a 150% gain is even fairly typical. The equivalent in the opposite direction comes in at a 75% loss. That would have been around $5. Instead the price was dropped to the last remaining uptrend line at about $.385 and bounced up off of that to right about a 75% loss. That “correction” was created by turning “good news into bad” AGAIN by fabrications about the importance of PFS and spoofing/shorting designed to take out stop losses and get non professional investors to panic sell creating even more momentum.
I stated once before that I believed that the damages should conservatively be noted (a good case could be made) to be about $5,000,000,000. Depending on what jurors might think the May 10th news should have been worth it could be more than that which you allude to. Citadel’s big profits from last year might be seen in a whole new light by jurors once discovery occurs. Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
